EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:750074 |
| ChEBI Name | brentuximab vedotin |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Role: | anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| brentuximab vedotin (CHEBI:750074) has role anti-HIV agent (CHEBI:64946) |
| brentuximab vedotin (CHEBI:750074) has role antineoplastic agent (CHEBI:35610) |
| brentuximab vedotin (CHEBI:750074) is a organic molecular entity (CHEBI:50860) |
| INNs | Source |
|---|---|
| brentuximab vedotina | WHO MedNet |
| brentuximab vedotine | WHO MedNet |
| Synonyms | Source |
|---|---|
| Brentuximab vedotin | ChEMBL |
| Brentuximab vedotin brentuximab | ChEMBL |
| CAC-10 | ChEMBL |
| CAC10 | ChEMBL |
| Cac10-1006(4) | ChEMBL |
| CAC10-VCMMAE | ChEMBL |
| Brand Name | Source |
|---|---|
| Adcetris | ChEMBL |